Verdict: mostly false, with an important dose-related qualification. CBD is not typically intoxicating in the way delta-9 THC is. A new randomized trial nevertheless found that healthy occasional cannabis users rated the pleasant drug effect slightly higher after 200 mg of synthetic CBD than after placebo. That finding changes an absolute “CBD has no noticeable effects” claim; it does not make CBD and THC interchangeable.
Seventy healthy occasional cannabis users completed a triple-blind, randomized crossover trial. Each person received placebo and single oral doses of 20, 50, 100 and 200 mg synthetic CBD after a high-fat meal. Only 200 mg significantly increased the study's primary “pleasant drug effect” rating.
What the New CBD Trial Found
Researchers at the Centre hospitalier de l'Université de Montréal tested five conditions in the same 70 adults: placebo plus 20, 50, 100 and 200 mg of synthetic CBD. The peer-reviewed trial report describes a triple-blind crossover design, meaning participants, investigators and analysts were masked and each participant served as their own comparison.
At 200 mg, the average peak score for a pleasant drug effect was 12.8% higher than placebo, with a moderate standardized effect estimate. The 20, 50 and 100 mg doses did not significantly change the primary outcome. The authors described the 200 mg result as slight but perceptible and concluded that single doses of 100 mg or less were unlikely to create a discernible psychoactive effect in healthy occasional users.
The registered clinical-trial record matters because it lets readers compare the planned design with the published report. It also makes clear that this was an acute dosing experiment, not a study of daily CBD use, a medical condition or long-term safety.
Is That the Same as a THC High?
No. The study measured participant ratings on a visual scale; it did not conclude that CBD recreated the euphoria, altered perception, memory changes or impairment associated with THC. “Pleasant drug effect” is a specific outcome, not a synonym for being stoned.
CBD and THC interact differently with the endocannabinoid system. The practical explanation in our cannabinoid guide is still useful: THC directly activates CB1 receptors strongly enough to produce the familiar cannabis high, while CBD has a different pharmacology. A measurable subjective effect at one CBD dose does not erase that difference.
Why the Meal and the 200 mg Dose Matter
Participants took CBD immediately after a high-fat meal. Food can substantially change oral cannabinoid absorption, so the same milligram amount taken fasting may not create the same blood exposure. The authors explicitly cautioned that the result may differ by fed state, clinical population and cannabis-use history.
Two hundred milligrams is also larger than many single servings in mass-market wellness products. Labels vary widely, however, and a bottle can contain multiple servings. Consumers should compare the amount per serving with the amount per container and should not assume a retail tincture reproduces the purity, formulation or dosing controls used in this study.
What the Study Cannot Tell Us
The participants were healthy occasional cannabis users. The results do not automatically apply to people taking CBD for epilepsy, pain, anxiety or sleep; people who use cannabis heavily; older adults; children; pregnant people; or those taking interacting medications. Every exposure was a single dose, so tolerance and repeated dosing were outside the design.
It also tested synthetic CBD, not a full-spectrum retail extract. A product labeled “CBD” can contain THC, other cannabinoids or contaminants. If someone reports a strong THC-like high from a CBD product, this trial does not prove that CBD caused it. Product contents and dose remain competing explanations.
CBD Can Be Non-Intoxicating and Still Be Pharmacologically Active
The strongest correction is not “CBD gets you high.” It is that non-intoxicating should never be translated into inactive or risk-free. The FDA warns that CBD can affect the liver, interact with medicines and cause side effects. Our broader CBD safety fact check explains those issues and the difference between an approved prescription medicine and nonprescription products.
For people who must avoid any psychoactive effect because of driving, safety-sensitive work, pregnancy, medication interactions or drug testing, an absolute marketing promise is not enough. Check the certificate of analysis, account for THC contamination risk and discuss clinically relevant CBD use with a pharmacist or qualified clinician. See our medication-interaction checklist for the information worth bringing to that conversation.
The Bottom Line
CBD did not produce a discernible subjective effect at 20, 50 or 100 mg in this 70-person experiment. At 200 mg after a high-fat meal, it produced a small increase in pleasant drug-effect ratings. That is credible evidence against the claim that CBD can never be felt, but it is not evidence that ordinary CBD use creates a classic THC high.
The buyer-intent takeaway is simple: prioritize verified CBD content, THC results and serving size over front-label promises such as “zero high.” Product quality determines whether the label matches the bottle; dose and context determine how the person may respond.